Picture1.png
CBIH Charts Path to Future Leadership in Cannabis Medicine
July 08, 2024 08:00 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
A letter from our desk HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Since the start of the year, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) has embarked on a transformative journey...
Medsenic, filiale de
Medsenic, filiale de BioSenic SA, étend un brevet clé aux États-Unis
July 05, 2024 01:00 ET | BioSenic
COMMUNIQUE DE PRESSE – INFORMATION PRIVILEGIEE  Une famille de brevets récents en cours de développement par Medsenic couvre l'utilisation thérapeutique de sels d'arsenic et d’ions métalliques par...
Medsenic, subsidiary
Medsenic, subsidiary of BioSenic SA, extends key patent to the United States
July 05, 2024 01:00 ET | BioSenic
PRESS RELEASE – PRIVILEGED INFORMATION  The developed Medsenic’s composition-of-matter patent family does cover the therapeutic use of arsenic salts and metal ions through various routes of...
ID Logo Medium PNG (Transparent Background).png
InterDigital signs license agreement with Google
July 02, 2024 04:00 ET | InterDigital, Inc.
InterDigital signed a new license agreement with Google to license InterDigital's cellular wireless, Wi-Fi, and HEVC video patented technologies
Picture1.png
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
July 01, 2024 08:00 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel treatm
clearmind.png
Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment
June 28, 2024 07:55 ET | Clearmind Medicine Inc.
Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
Cyclacel Pharmaceuticals logo
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
June 26, 2024 09:15 ET | Cyclacel
NOTICE OF INTENTION TO GRANT OF NEW EUROPEAN PATENT COVERING PLOGOSERTIB PHARMACEUTICAL COMPOSITIONS - Lengthens Patent Exclusivity to August 2040
Logo_Anaqua-Color.png
アナクアがAI活用機能などを含む知財管理プラットフォームの新バージョン AQX® 11をリリース
June 26, 2024 08:00 ET | Anaqua
ボストン, June 26, 2024 (GLOBE NEWSWIRE) -- 知的財産管理とイノベーション管理ソリューションの業界トップクラスのテクノロジープロバイダーである米国アナクア社(Anaqua)が、AIを活用した管理システムの新バージョン AQX®...
Logo_Anaqua-Color.png
Anaqua lance la plateforme de gestion PI AQX® 11, alimentée par l'IA
June 26, 2024 08:00 ET | Anaqua
BOSTON, 26 juin 2024 (GLOBE NEWSWIRE) -- Anaqua, fournisseur leader de technologies de gestion de l'innovation et de la propriété intellectuelle (PI), annonce aujourd'hui le lancement d'AQX® 11,...
Logo_Anaqua-Color.png
Anaqua Launches AI-Powered IP Management Platform AQX® 11
June 26, 2024 08:00 ET | Anaqua
New IP management platform drives efficiency and surfaces insights empowering organizations to excel in a competitive landscape